Shi-Jiang Lu
Chief Executive Officer at HebeCell Corp.
Profile
Shi-Jiang Lu is the founder of HebeCell Corp., where he currently holds the titles of President & Chief Executive Officer.
He founded the company in 2016.
In addition to his founding position, Dr. Lu also held the title of Senior Director-Research at Astellas Institute for Regenerative Medicine in the past.
Shi-Jiang Lu active positions
| Companies | Position | Start |
|---|---|---|
HebeCell Corp.
 HebeCell Corp. BiotechnologyHealth Technology HebeCell Corp. is a biotech company that develops universal and cost-effective NK cell therapeutics for the treatment of cancer, viral infection, and autoimmune diseases. The company is based in Natick, MA, which is one of the world's largest biotech hubs. HebeCell's proprietary 3D pluripotent stem cell platform allows for the creation of off-the-shelf Protonk™ cell products that are readily available to patients worldwide. The company was founded in 2016 by Shi-Jiang Lu, who has been the CEO since then. | Chief Executive Officer | 2015-12-31 |
Former positions of Shi-Jiang Lu
| Companies | Position | End |
|---|---|---|
| OCATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
HebeCell Corp.
HebeCell Corp. BiotechnologyHealth Technology HebeCell Corp. is a biotech company that develops universal and cost-effective NK cell therapeutics for the treatment of cancer, viral infection, and autoimmune diseases. The company is based in Natick, MA, which is one of the world's largest biotech hubs. HebeCell's proprietary 3D pluripotent stem cell platform allows for the creation of off-the-shelf Protonk™ cell products that are readily available to patients worldwide. The company was founded in 2016 by Shi-Jiang Lu, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Shi-Jiang Lu